These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Safety and efficacy of once-daily gastroretentive gabapentin in patients with postherpetic neuralgia aged 75 years and over. Gupta A, Li S. Drugs Aging; 2013 Dec; 30(12):999-1008. PubMed ID: 24163280 [Abstract] [Full Text] [Related]
31. A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia. O'Connor AB, Noyes K, Holloway RG. J Am Geriatr Soc; 2007 Aug; 55(8):1176-84. PubMed ID: 17661955 [Abstract] [Full Text] [Related]
32. A cost-utility comparison of four first-line medications in painful diabetic neuropathy. O'Connor AB, Noyes K, Holloway RG. Pharmacoeconomics; 2008 Aug; 26(12):1045-64. PubMed ID: 19014205 [Abstract] [Full Text] [Related]
33. PHARMACOKINETIC PROPERTIES OF A SINGLE ADMINISTRATION OF ORAL GABAPENTIN IN THE GREAT HORNED OWL (BUBO VIRGINIANUS). Yaw TJ, Zaffarano BA, Gall A, Olds JE, Wulf L, Papastavros E, Coetzee JF. J Zoo Wildl Med; 2015 Sep; 46(3):547-52. PubMed ID: 26352959 [Abstract] [Full Text] [Related]
34. Gabapentin to pregabalin therapy transition: a pharmacokinetic simulation. Bockbrader HN, Budhwani MN, Wesche DL. Am J Ther; 2013 Jan; 20(1):32-6. PubMed ID: 23018586 [Abstract] [Full Text] [Related]